MiR-153 is significantly down-regulated in glioma compared with normal brain tissues and decreases cell proliferation and increases apoptosis by targeting B cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) genes in glioma cell lines [23]. The gene discussed is BCL2; the disease is glioma.